Methods of treating hidradenitis suppurativa
US11844790B2 · kind B2 · utility
0Cited by
15References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 2021 |
| Grant date | Dec 19, 2023 |
| Priority date | — |
| Expiry date | Oct 27, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for treating a subject suffering from a cutaneous neutrophilic inflammatory disease comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula Ior a pharmaceutically acceptable salt thereof, wherein each variable position is as defined herein. In some embodiments, the cutaneous neutrophilic inflammatory disease is Hidradenitis suppurativa (HS).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.